Generic Desvenlafaxine 50 mg Extended-
Sponsors
International Bio Service
Conditions
Healthy Thai Volunteers
Phase 1
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product (Pristiqâ„¢ 50 mg) in Healthy Thai Volunteers under Fasting Conditions - Pilot Study
Active, not recruitingTCTR20180924002
Start: 2018-11-30Target: 10Updated: 2026-08-03
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product (Pristiqâ„¢ 50 mg) in Healthy Thai Volunteers under Fed and Fasting Conditions
RecruitingTCTR20181115008
Start: 2018-11-12Target: 28Updated: 2026-08-03
An Open Label, Randomized, Two-treatment, Two-period, Two-sequence, Multiple Oral Dose, Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product (Pristiqâ„¢ 50 mg) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20190417006
Start: 2019-04-11Target: 32Updated: 2026-08-03